|
Martinez-Garcia, J; Boix, AP; Henarejos, PS; Lucas, MDJ; Saura, AS; Luengo, M; Vicente, RC; Ortiz, MJM; Balsalobre, J; Barrio, PDLMD; Garre, EG; Garcia, E; Marin, G; Torralba, EG; de la Pena, FA; Collado, D; Lopez, A; Quiros, T; Sanchez, DA; Romero, JLA. Trastuzumab emtansine in HER2-positive metastatic breast cancer after pertuzumab and trastuzumab: TDM1RM Study. ANNALS OF ONCOLOGY. 2020; 31:S358-S358. 10.1016/j.annonc.2020.08.393
AÑO: 2020; IF: 32.976
|
|
Castillo-Guardiola V, Rosado-Jimenez L, Sarabia-Meseguer MD, Marin-Vera M, Macias-Cerrolaza JA, Garcia-Hernandez R, Zafra-Poves M, Sanchez-Henarejos P, Moreno-Locubiche MA, Cuevas-Tortosa E, Arnaldos-Carrillo M, Ayala de la Pena F, Alonso-Romero JL, Noguera-Velasco JA, Ruiz-Espejo F. Next step in molecular genetics of hereditary breast/ovarian cancer: Multigene panel testing in clinical actionably genes and prioritization algorithms in the study of variants of uncertain significance. Eur J Med Genet. 2022 Apr;65(4):104468. doi: 10.1016/j.ejmg.2022.104468. Epub 2022 Mar 1. PubMed PMID: 35245693.
AÑO: 2022; IF: 1.9
|
|
Sanchez Martinez DA, Salas-Lucia F, Jiang H, Ruiz-Carreno P, Alonso Romero JL. Drug cost avoidance analysis of cancer clinical trials in Spain: a study on cost contributors and their impact. BMC Health Serv Res. 2022 Jul 26;22(1):948. doi: 10.1186/s12913-022-08222-9. PubMed PMID: 35883128; PubMed Central PMCID: PMC9316356.
AÑO: 2022; IF: 2.908
|
|
Rosado-Jimenez L, Mestre-Terkemani Y, Garcia-Aliaga A, Marin-Vera M, Macias-Cerrolaza JA, Sarabia-Meseguer MD, Garcia-Hernandez MR, Zafra-Poves M, Sanchez-Henarejos P, Ayala de la Pena F, Alonso-Romero JL, Noguera-Velasco JA, Ruiz-Espejo F. Variantes geneticas recurrentes y priorizacion de variantes de significado clinico desconocido asociadas al sindrome de cancer de mama y ovario hereditario en familias de la Region de Murcia. Adv Lab Med. 2023 Jul 10;4(3):288-297. doi: 10.1515/almed-2023-0032. eCollection 2023 Sep. Spanish. PubMed PMID: 38075173; PubMed Central PMCID: PMC10701495.
AÑO: 2023; IF: 1.0
|
|
Encarnacion JA, Morillo Macias V, De la Fuente Munoz I, Soria VD, Fernandez Fornos L, Antequera MA, Rey OA, Garcia Martinez V, Alonso-Romero JL, Garcia Gomez R. Apalutamide and Stereotactic Body Radiotherapy in Metastatic Hormone-Sensitive Prostate Cancer: Multicenter Real-World Study. Cancers (Basel). 2025 Jul 2;17(13):2216. doi: 10.3390/cancers17132216. PubMed PMID: 40647514; PubMed Central PMCID: PMC12249003.
AÑO: 2025; IF: 4.4
|